CSM
ABBV icon

CAMG Solamere Management’s AbbVie ABBV Stock Holding History

CAMG Solamere Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,805
Closed -$275K – 115
2020
Q2 		$275K Sell
2,805
-300
-10% -$26.4K 0.15% 102
2020
Q1 		$237K Sell
3,105
-75
-2% -$6.39K 0.12% 109
2019
Q4 		$281K Hold
3,180
– – 0.13% 81
2019
Q3 		$241K Buy
3,180
+200
+7% +$13.7K 0.12% 85
2019
Q2 		$216K Buy
2,980
+100
+3% +$7.86K 0.1% 91
2019
Q1 		$231K Hold
2,880
– – 0.11% 93
2018
Q4 		$264K Sell
2,880
-744
-21% -$65.4K 0.15% 85
2018
Q3 		$343K Sell
3,624
-1,284
-26% -$122K 0.18% 83
2018
Q2 		$454K Sell
4,908
-272
-5% -$26.6K 0.22% 86
2018
Q1 		$491K Buy
5,180
+119
+2% +$13.1K 0.22% 98
2017
Q4 		$491K Buy
5,061
+79
+2% +$7.45K 0.22% 98
2017
Q3 		$442K Hold
4,982
– – 0.22% 100
2017
Q2 		$361K Buy
4,982
+3
+0.1% +$202 0.21% 102
2017
Q1 		$325K Sell
4,979
-876
-15% -$55.1K 0.19% 105
2016
Q4 		$367K Buy
+5,855
New +$357K 0.26% 98

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

CAMG Solamere Management's ABBV Position: Q3 2020 in Review

CAMG Solamere Management sold out of AbbVie (ABBV) in Q3 2020, closing a stake of 2,805 shares — an estimated $275K sold.

CAMG Solamere Management first reported a position in ABBV in Q4 2016 and held it in 15 quarters. The position peaked at $491K in Q1 2018. 2,366 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

  • CAMG Solamere Management reported no remaining AbbVie position as of Q3 2020 after selling out during the quarter.
  • CAMG Solamere Management sold 2,805 AbbVie shares in Q3 2020, an estimated $275K.
  • CAMG Solamere Management first reported a position in AbbVie in Q4 2016 and held it in 15 quarters.
  • CAMG Solamere Management's AbbVie position peaked at $491K in Q1 2018.
  • 2,366 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on CAMG Solamere Management's 13F filing for Q3 2020, filed 16 Nov 2020.